The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice

  1. Camille Dumon
  2. Diabe Diabira
  3. Ilona Chudotvorova
  4. Francesca Bader  Is a corresponding author
  5. Semra Sahin
  6. Jinwei Zhang
  7. Christophe Porcher
  8. Gary Wayman
  9. Igor Medina
  10. Jean-Luc Gaiarsa  Is a corresponding author
  1. Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), France
  2. Washington State University, United States
  3. University of Exeter Medical School, United Kingdom

Abstract

Brain computations rely on a proper balance between excitation and inhibition which progressively emerges during postnatal development in rodent. g-aminobutyric acid (GABA) neurotransmission supports inhibition in the adult brain but excites immature rodent neurons. Alterations in the timing of the GABA switch contribute to neurological disorders, so unveiling the involved regulators may be a promising strategy for treatment. Here we show that the adipocyte hormone leptin sets the tempo for the emergence of GABAergic inhibition in the newborn rodent hippocampus. In the absence of leptin signaling, hippocampal neurons show an advanced emergence of GABAergic inhibition. Conversely, maternal obesity associated with hyperleptinemia delays the excitatory to inhibitory switch of GABA action in offspring. This study uncovers a developmental function of leptin that may be linked to the pathogenesis of neurological disorders and helps understanding how maternal environment can adversely impact offspring brain development.

Data availability

All data generated or analyszed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 to 4 and Supplementary Figures 1 and 2.

Article and author information

Author details

  1. Camille Dumon

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Diabe Diabira

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Ilona Chudotvorova

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Francesca Bader

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    For correspondence
    francesca.bader@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  5. Semra Sahin

    Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jinwei Zhang

    Institute of Biochemical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8683-509X
  7. Christophe Porcher

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Gary Wayman

    Department of Integrative Physiology and Neuroscience, Washington State University, Pullman, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Igor Medina

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6839-5414
  10. Jean-Luc Gaiarsa

    INMED (Institut de Neurobiologie de la Méditerranée), Aix-Marseille University UMR 1249, INSERM (Institut National de la Santé et de la Recherche Médicale), Marseille, France
    For correspondence
    jean-luc.gaiarsa@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7354-0559

Funding

National Institutes of Health (Grant MH086032)

  • Gary Wayman

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal procedures were carried out in accordance with the European Union Directive of 22 September (2010/63/EU).

Copyright

© 2018, Dumon et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,801
    views
  • 255
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Camille Dumon
  2. Diabe Diabira
  3. Ilona Chudotvorova
  4. Francesca Bader
  5. Semra Sahin
  6. Jinwei Zhang
  7. Christophe Porcher
  8. Gary Wayman
  9. Igor Medina
  10. Jean-Luc Gaiarsa
(2018)
The adipocyte hormone leptin sets the emergence of hippocampal inhibition in mice
eLife 7:e36726.
https://doi.org/10.7554/eLife.36726

Share this article

https://doi.org/10.7554/eLife.36726

Further reading

    1. Neuroscience
    Jacob A Miller
    Insight

    When navigating environments with changing rules, human brain circuits flexibly adapt how and where we retain information to help us achieve our immediate goals.

    1. Neuroscience
    Gáspár Oláh, Rajmund Lákovics ... Gábor Tamás
    Research Article

    Human-specific cognitive abilities depend on information processing in the cerebral cortex, where the neurons are significantly larger and their processes longer and sparser compared to rodents. We found that, in synaptically connected layer 2/3 pyramidal cells (L2/3 PCs), the delay in signal propagation from soma to soma is similar in humans and rodents. To compensate for the longer processes of neurons, membrane potential changes in human axons and/or dendrites must propagate faster. Axonal and dendritic recordings show that the propagation speed of action potentials (APs) is similar in human and rat axons, but the forward propagation of excitatory postsynaptic potentials (EPSPs) and the backward propagation of APs are 26 and 47% faster in human dendrites, respectively. Experimentally-based detailed biophysical models have shown that the key factor responsible for the accelerated EPSP propagation in human cortical dendrites is the large conductance load imposed at the soma by the large basal dendritic tree. Additionally, larger dendritic diameters and differences in cable and ion channel properties in humans contribute to enhanced signal propagation. Our integrative experimental and modeling study provides new insights into the scaling rules that help maintain information processing speed albeit the large and sparse neurons in the human cortex.